Literature DB >> 27433943

Serum levels of Lp(a) are related to waist circumference in NAFLD patients with low prevalence of co-morbidities.

Giovanni Tarantino1,2, Carmine Finelli3, Saverio Gioa3, Vincenzo Citro4, Nicolina La Sala3, Marco Gentile1.   

Abstract

BACKGROUND: Novel evidence suggests a relationship between circulating Lp(a) levels and the presence of cardiovascular events independently from the cardio-metabolic profile. METHODS AND
RESULTS: The purpose of this study was to investigate serum Lp(a) concentrations in relation to carotid intima-media thickness (IMT), anthropometric measures, lipid profile, assessment of insulin resistance, and other parameters conventionally used to predict CVD risk, in obese patients suffering from hepatic steatosis (HS), the well-known nonalcoholic fatty liver disease (NAFLD). Evidencing the key-points of this research, firstly, serum Lp(a) concentrations were not associated with carotid IMT in this selected population or, consequently, with early atherosclerosis, at least as evaluated by IMT. Secondly, carotid IMT was not predicted by HS severity, as evaluated by ultrasound. Finally, in the adjusted model, Lp(a) was positively predicted by waist circumference (WC) (β = 0.25, t = 2.3, p = 0.02) and negatively by central adiposity, assessed as visceral adipose tissue at US (β = -0.33, t = -3.0, p = 0.003).
CONCLUSION: Serum Lp(a) values may not play a direct role in increasing IMT, albeit associated with WC.

Entities:  

Keywords:  Carotid intima-media; Lp(a); NAFLD; obesity; waist circumference

Mesh:

Substances:

Year:  2016        PMID: 27433943     DOI: 10.1080/00365513.2016.1207249

Source DB:  PubMed          Journal:  Scand J Clin Lab Invest        ISSN: 0036-5513            Impact factor:   1.713


  3 in total

1.  Study on the relationship between hormone and Lp(a) in Chinese overweight/obese patients.

Authors:  Xiaona Chang; Nannan Bian; Xiaoyu Ding; Jinman Li; Yu An; Jiaxuan Wang; Jia Liu; Guang Wang
Journal:  BMC Endocr Disord       Date:  2022-05-16       Impact factor: 3.263

2.  Lipoprotein A, combined with alanine aminotransferase and aspartate aminotransferase, contributes to predicting the occurrence of NASH: a cross-sectional study.

Authors:  Yu Zhang; He He; Yu-Ping Zeng; Li-Dan Yang; Dan Jia; Zhen-Mei An; Wei-Guo Jia
Journal:  Lipids Health Dis       Date:  2020-06-11       Impact factor: 3.876

3.  Urine Proteome in Distinguishing Hepatic Steatosis in Patients with Metabolic-Associated Fatty Liver Disease.

Authors:  Chang-Hai Liu; Shanshan Zheng; Shisheng Wang; Dongbo Wu; Wei Jiang; Qingmin Zeng; Yi Wei; Yong Zhang; Hong Tang
Journal:  Diagnostics (Basel)       Date:  2022-06-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.